Cargando…
Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer
Although significant progress has been made in the past decade in the treatment of both common and rare cancers, there has been significant concerns about the cost, and especially the value, of certain new oncology drugs. These concerns touch upon a number of issues regarding the price of these medi...
Autores principales: | Barron, Anthony, Wilsdon, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110579/ https://www.ncbi.nlm.nih.gov/pubmed/27917036 http://dx.doi.org/10.1007/s40290-016-0167-1 |
Ejemplares similares
-
The Whole Price of Vancomycin: Toxicities, Troughs, and Time
por: Jeffres, Meghan N.
Publicado: (2017) -
Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
por: Paliard, Xavier, et al.
Publicado: (2019) -
Comparability Considerations and Challenges for Expedited Development Programs for Biological Products
por: Schrieber, Sarah J., et al.
Publicado: (2020) -
Ethical Hurdles in the Prioritization of Oncology Care
por: de Groot, Folkert, et al.
Publicado: (2016) -
Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
por: O’Mahony, James F.
Publicado: (2021)